LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that ...
The diagnostics advisory committee considered evidence on Deep Ensemble for Recognition of Malignancy (DERM) to assess and triage skin lesions referred to the urgent suspected skin cancer pathway from ...
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the topline results ...
A team led by researchers from Nagoya University in Japan has discovered new pathways that cells use to repair themselves following exposure to ultraviolet (UV) light, and a new agent involved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback